These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 23933235

  • 1. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.
    Abu Lila AS, Kiwada H, Ishida T.
    J Control Release; 2013 Nov 28; 172(1):38-47. PubMed ID: 23933235
    [Abstract] [Full Text] [Related]

  • 2. A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.
    Shimizu T, Abu Lila AS, Fujita R, Awata M, Kawanishi M, Hashimoto Y, Okuhira K, Ishima Y, Ishida T.
    Eur J Pharm Biopharm; 2018 Jun 28; 127():142-149. PubMed ID: 29462689
    [Abstract] [Full Text] [Related]

  • 3. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
    Abu Lila AS, Nawata K, Shimizu T, Ishida T, Kiwada H.
    Int J Pharm; 2013 Nov 01; 456(1):235-42. PubMed ID: 23928149
    [Abstract] [Full Text] [Related]

  • 4. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.
    Ishida T, Kiwada H.
    Int J Pharm; 2008 Apr 16; 354(1-2):56-62. PubMed ID: 18083313
    [Abstract] [Full Text] [Related]

  • 5. [Recent advances in the study of accelerated blood clearance phenomenon of PEGylated liposomes].
    Xu H, Wang KQ, Huang WW, Deng YH, Chen DW.
    Yao Xue Xue Bao; 2010 Jun 16; 45(6):677-83. PubMed ID: 20939173
    [Abstract] [Full Text] [Related]

  • 6. Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon.
    Shimizu T, Ishida T, Kiwada H.
    Immunobiology; 2013 May 16; 218(5):725-32. PubMed ID: 22995937
    [Abstract] [Full Text] [Related]

  • 7. Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.
    Hashimoto Y, Shimizu T, Abu Lila AS, Ishida T, Kiwada H.
    Biol Pharm Bull; 2015 May 16; 38(3):417-24. PubMed ID: 25757923
    [Abstract] [Full Text] [Related]

  • 8. Accelerated blood clearance of pegylated liposomal topotecan: influence of polyethylene glycol grafting density and animal species.
    Li C, Cao J, Wang Y, Zhao X, Deng C, Wei N, Yang J, Cui J.
    J Pharm Sci; 2012 Oct 16; 101(10):3864-76. PubMed ID: 22777607
    [Abstract] [Full Text] [Related]

  • 9. Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.
    Shimizu T, Mima Y, Hashimoto Y, Ukawa M, Ando H, Kiwada H, Ishida T.
    Immunobiology; 2015 Oct 16; 220(10):1151-60. PubMed ID: 26095176
    [Abstract] [Full Text] [Related]

  • 10. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes.
    Ishida T, Ichihara M, Wang X, Kiwada H.
    J Control Release; 2006 Oct 27; 115(3):243-50. PubMed ID: 17011060
    [Abstract] [Full Text] [Related]

  • 11. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome.
    Abu Lila AS, Ichihara M, Shimizu T, Ishida T, Kiwada H.
    Biol Pharm Bull; 2013 Oct 27; 36(11):1842-8. PubMed ID: 24189428
    [Abstract] [Full Text] [Related]

  • 12. Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.
    Wang C, Cheng X, Su Y, Pei Y, Song Y, Jiao J, Huang Z, Ma Y, Dong Y, Yao Y, Fan J, Ta H, Liu X, Xu H, Deng Y.
    Int J Nanomedicine; 2015 Oct 27; 10():3533-45. PubMed ID: 25999716
    [Abstract] [Full Text] [Related]

  • 13. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes.
    Koide H, Asai T, Hatanaka K, Akai S, Ishii T, Kenjo E, Ishida T, Kiwada H, Tsukada H, Oku N.
    Int J Pharm; 2010 Jun 15; 392(1-2):218-23. PubMed ID: 20227473
    [Abstract] [Full Text] [Related]

  • 14. Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein.
    Mima Y, Hashimoto Y, Shimizu T, Kiwada H, Ishida T.
    Mol Pharm; 2015 Jul 06; 12(7):2429-35. PubMed ID: 26070445
    [Abstract] [Full Text] [Related]

  • 15. [Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers].
    Koide H, Asai T, Hatanaka K, Shimizu K, Yokoyama M, Ishida T, Kiwada H, Oku N.
    Yakugaku Zasshi; 2009 Dec 06; 129(12):1445-51. PubMed ID: 19952519
    [Abstract] [Full Text] [Related]

  • 16. [Accelerated blood clearance (ABC) phenomenon induced by administration of PEGylated liposome].
    Ishida T, Kiwada H.
    Yakugaku Zasshi; 2008 Feb 06; 128(2):233-43. PubMed ID: 18239370
    [Abstract] [Full Text] [Related]

  • 17. Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon.
    El Sayed MM, Takata H, Shimizu T, Kawaguchi Y, Abu Lila AS, Elsadek NE, Alaaeldin E, Ishima Y, Ando H, Kamal A, Sarhan HA, Ishida T.
    J Control Release; 2020 Jul 10; 323():102-109. PubMed ID: 32278827
    [Abstract] [Full Text] [Related]

  • 18. Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM.
    Wang F, Ye X, Wu Y, Wang H, Sheng C, Peng D, Chen W.
    J Pharm Sci; 2019 Jan 10; 108(1):641-651. PubMed ID: 30595169
    [Abstract] [Full Text] [Related]

  • 19. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
    Abu Lila AS, Uehara Y, Ishida T, Kiwada H.
    J Pharm Sci; 2014 Feb 10; 103(2):557-66. PubMed ID: 24347396
    [Abstract] [Full Text] [Related]

  • 20. Differences in colloidal structure of PEGylated nanomaterials dictate the likelihood of accelerated blood clearance.
    Kaminskas LM, McLeod VM, Porter CJ, Boyd BJ.
    J Pharm Sci; 2011 Nov 10; 100(11):5069-77. PubMed ID: 21721002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.